Build a Company-wide Digital Infrastructure & Enhance Productivity Across All Value Chains

By leveraging digital technology and globally standardized IT infrastructure, we aim to significantly enhance the productivity of our business processes.

Platform for human resource development: CHUGAI DIGITAL ACADEMY

CHUGAI DIGITAL ACADEMY (CDA) is a comprehensive program established to systematically develop in-house digital talents such as business architects and data scientists. The program provides a full range of content including e-Learning, practical exercises through group work, on-the-job training, and assignments to actual projects. Furthermore, through external training programs, human resource exchanges, and collaboration with universities and research institutions, we aim to enhance skills and experience in pharmaceuticals and digital technology. By giving back to society the knowledge, skills, experience, and mindset of “pharmaceuticals × digital” that our company has acquired, we strive to form an ecosystem of digital talent.

Chugai Cloud Infrastructure(CCI)

Chugai has built Chugai Cloud Infrastructure (CCI) as a common company-wide digital IT platform to support the Enhancing the R&D domain through digital utilization and improving productivity across the entire value chain.
By centralizing infrastructure functions in a multi-cloud environment, we promote standardization, strengthen security governance, and efficiently manage integrated operations.
It is a digital IT foundation that covers both the Scientific and Enterprise domains and underpins all value chains.

Smart Factory

The wave of digital technology is also reaching the manufacturing sector of the pharmaceutical industry. By integrating digital technologies into our manufacturing sites, we aim to generate new value through improved productivity, consistent quality, enhanced compliance, and work satisfaction reform. These initiatives are critical to shaping the future of pharmaceutical manufacturing.
At our company, we are proactively implementing these technologies to build the smart factories of the future.

DCT

We are promoting Decentralized Clinical Trials (DCTs), which differ from conventional clinical trials that rely on patient visits, as an initiative to reduce the burden of hospital visits for patients participating in clinical trials and shorten the drug development period. DCTs utilize digital technologies such as online medical consultations, eConsent, and wearable devices.

AI Agent